ウイルス分子診断の世界市場

◆英語タイトル:Viral Molecular Diagnostics - Global Market Outlook (2015-2022)
◆商品コード:SMRC65214
◆発行会社(調査会社):Stratistics MRC
◆発行日:2016年3月
◆ページ数:138
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD4,150 ⇒換算¥460,650見積依頼/購入/質問フォーム
2-5 UserUSD5,250 ⇒換算¥582,750見積依頼/購入/質問フォーム
Global Site LicenseUSD7,500 ⇒換算¥832,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はStratistics MRC社の日本における正規販売代理店です。Stratistics MRC社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、ウイルス分子診断の世界市場について調査・分析し、市場動向、市場規模、市場予測、企業動向などを含め、以下の構成でお届けいたします。

・エグゼクティブサマリー
・序文
・市場動向分析
・ファイブフォース分析(市場環境分析)
・ウイルス分子診断の世界市場:用途別分析/市場規模
・ウイルス分子診断の世界市場:技術別分析/市場規模
・ウイルス分子診断の世界市場:需要先別分析/市場規模
・ウイルス分子診断の世界市場:製品別分析/市場規模
・ウイルス分子診断の世界市場:地域別分析/市場規模
・ウイルス分子診断のアメリカ市場規模予測
・ウイルス分子診断のヨーロッパ市場規模予測
・ウイルス分子診断のアジア市場規模予測
・企業動向
・企業分析
【レポートの概要】

According to Stratistics MRC, the Global Viral Molecular Diagnostics Market accounted for $XX million in 2015 and is expected to grow at a CAGR of XX% to reach $XX million by 2022. Growing incidence of viral diseases, rising aged population, technological advances in molecular diagnostics, increasing awareness about viral diseases and rising government initiatives in several regions are the key factors fueling the market growth. On the other hand, absence of skilled professionals and huge cost of molecular diagnostics are some of the key factors limiting the viral molecular diagnostics market growth.North America is the major market for the viral molecular diagnostics followed by the Western Europe owing to growing number of key players within this market. Superior infrastructure and top awareness levels about various viral diseases among the people in these regions are the key factors attributed for their highest share. Asia-Pacific is the fastest growing market for various viral molecular diagnostic tests, owing to growing incidence of viral infections in this market.
Some of the key players in the global viral molecular diagnostics market include Meridian Bioscience Inc., Becton Dickinson and Company, F. Hoffmann-La Roche Ltd., Abbott Laboratories Inc., Thermo Fisher Scientific Corporation, BioMerieux SA, Auto Genomics Inc., Qiagen NV, Affymetrix Inc., Illumina Inc., Gen-Probe Inc., Roche Molecular Diagnostics, Siemens, Cepheid and Beckman Coulter.

Applications Covered:
• Respiratory Syncytial Virus
• Hepatitis
• AIDS
• Influenza
• Others
Technologies Covered:
• Real time PCR (RT-PCR)
• Polymerase chain reaction (PCR)
• Nucleic Acid Sequence Based Amplification
• Other Molecular Diagnostic methods
o Isothermal nucleic acid amplification technology (INAAT)
o Microarrays
o In situ hybridization
End User’s Covered:
• Academic Institutions
• Hospitals
• Ambulatory clinics
• Diagnostic Laboratories
Products Covered:
• Reagents
• Instrument
• Others
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

【レポートの目次】

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Product Analysis
3.10 Emerging markets

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Viral Molecular Diagnostics Market, By Application
5.1 Introduction
5.2 Respiratory Syncytial Virus
5.3 Hepatitis
5.4 AIDS
5.5 Influenza
5.6 Other Applications

6 Global Viral Molecular Diagnostics Market, By Technology
6.1 Introduction
6.2 Real time PCR (RT-PCR)
6.3 Polymerase chain reaction (PCR)
6.4 Nucleic Acid Sequence Based Amplification
6.5 Other Molecular Diagnostic methods
6.5.1 Isothermal nucleic acid amplification technology (INAAT)
6.5.2 Microarrays
6.5.3 In situ hybridization

7 Global Viral Molecular Diagnostics Market, By End User
7.1 Introduction
7.2 Academic Institutions
7.3 Hospitals
7.4 Ambulatory clinics
7.5 Diagnostic Laboratories

8 Global Viral Molecular Diagnostics Market, By Product
8.1 Introduction
8.2 Reagents
8.3 Instrument
8.4 Other Products

9 Global Viral Molecular Diagnostics Market, By Geography
9.1 North America
9.1.1 US
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 UK
9.2.5 Spain
9.2.6 Rest of Europe
9.3 Asia Pacific
9.3.1 Japan
9.3.2 China
9.3.3 India
9.3.4 Australia
9.3.5 New Zealand
9.3.6 Rest of Asia Pacific
9.4 Rest of the World
9.4.1 Middle East
9.4.2 Brazil
9.4.3 Argentina
9.4.4 South Africa
9.4.5 Egypt

10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 Company Profiling
11.1 Meridian Bioscience Inc.
11.2 Becton Dickinson and Company
11.3 F. Hoffmann-La Roche Ltd.
11.4 Abbott Laboratories Inc.
11.5 Thermo Fisher Scientific Corporation
11.6 BioMerieux SA
11.7 Auto Genomics Inc.
11.8 Qiagen NV
11.9 Affymetrix Inc.
11.10 Illumina Inc.
11.11 Gen-Probe Inc.
11.12 Roche Molecular Diagnostics
11.13 Siemens
11.14 Cepheid
11.15 Beckman Coulter

List of Tables
Table 1 Global Viral Molecular Diagnostics Market Outlook, By Region (2013-2022) ($MN)
Table 2 Global Viral Molecular Diagnostics Market Outlook, By Application (2013-2022) ($MN)
Table 3 Global Viral Molecular Diagnostics Market Outlook, By Respiratory Syncytial Virus (2013-2022) ($MN)
Table 4 Global Viral Molecular Diagnostics Market Outlook, By Hepatitis (2013-2022) ($MN)
Table 5 Global Viral Molecular Diagnostics Market Outlook, By AIDS (2013-2022) ($MN)
Table 6 Global Viral Molecular Diagnostics Market Outlook, By Influenza (2013-2022) ($MN)
Table 7 Global Viral Molecular Diagnostics Market Outlook, By Other Applications (2013-2022) ($MN)
Table 8 Global Viral Molecular Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
Table 9 Global Viral Molecular Diagnostics Market Outlook, By Real time PCR (RT-PCR) (2013-2022) ($MN)
Table 10 Global Viral Molecular Diagnostics Market Outlook, By Polymerase chain reaction (PCR) (2013-2022) ($MN)
Table 11 Global Viral Molecular Diagnostics Market Outlook, By Nucleic Acid Sequence Based Amplification (2013-2022) ($MN)
Table 12 Global Viral Molecular Diagnostics Market Outlook, By Other Molecular Diagnostic methods (2013-2022) ($MN)
Table 13 Global Viral Molecular Diagnostics Market Outlook, By End User (2013-2022) ($MN)
Table 14 Global Viral Molecular Diagnostics Market Outlook, By Academic Institutions (2013-2022) ($MN)
Table 15 Global Viral Molecular Diagnostics Market Outlook, By Hospitals (2013-2022) ($MN)
Table 16 Global Viral Molecular Diagnostics Market Outlook, By Ambulatory clinics (2013-2022) ($MN)
Table 17 Global Viral Molecular Diagnostics Market Outlook, By Diagnostic Laboratories (2013-2022) ($MN)
Table 18 Global Viral Molecular Diagnostics Market Outlook, By Product Type (2013-2022) ($MN)
Table 19 Global Viral Molecular Diagnostics Market Outlook, By Reagents (2013-2022) ($MN)
Table 20 Global Viral Molecular Diagnostics Market Outlook, By Instrument (2013-2022) ($MN)
Table 21 Global Viral Molecular Diagnostics Market Outlook, By Other Products (2013-2022) ($MN)
Table 22 North America Viral Molecular Diagnostics Market Outlook, By Application (2013-2022) ($MN)
Table 23 North America Viral Molecular Diagnostics Market Outlook, By Respiratory Syncytial Virus (2013-2022) ($MN)
Table 24 North America Viral Molecular Diagnostics Market Outlook, By Hepatitis (2013-2022) ($MN)
Table 25 North America Viral Molecular Diagnostics Market Outlook, By AIDS (2013-2022) ($MN)
Table 26 North America Viral Molecular Diagnostics Market Outlook, By Influenza (2013-2022) ($MN)
Table 27 North America Viral Molecular Diagnostics Market Outlook, By Other Applications (2013-2022) ($MN)
Table 28 North America Viral Molecular Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
Table 29 North America Viral Molecular Diagnostics Market Outlook, By Real time PCR (RT-PCR) (2013-2022) ($MN)
Table 30 North America Viral Molecular Diagnostics Market Outlook, By Polymerase chain reaction (PCR) (2013-2022) ($MN)
Table 31 North America Viral Molecular Diagnostics Market Outlook, By Nucleic Acid Sequence Based Amplification (2013-2022) ($MN)
Table 32 North America Viral Molecular Diagnostics Market Outlook, By Other Molecular Diagnostic methods (2013-2022) ($MN)
Table 33 North America Viral Molecular Diagnostics Market Outlook, By End User (2013-2022) ($MN)
Table 34 North America Viral Molecular Diagnostics Market Outlook, By Academic Institutions (2013-2022) ($MN)
Table 35 North America Viral Molecular Diagnostics Market Outlook, By Hospitals (2013-2022) ($MN)
Table 36 North America Viral Molecular Diagnostics Market Outlook, By Ambulatory clinics (2013-2022) ($MN)
Table 37 North America Viral Molecular Diagnostics Market Outlook, By Diagnostic Laboratories (2013-2022) ($MN)
Table 38 North America Viral Molecular Diagnostics Market Outlook, By Product Type (2013-2022) ($MN)
Table 39 North America Viral Molecular Diagnostics Market Outlook, By Reagents (2013-2022) ($MN)
Table 40 North America Viral Molecular Diagnostics Market Outlook, By Instrument (2013-2022) ($MN)
Table 41 North America Viral Molecular Diagnostics Market Outlook, By Other Products (2013-2022) ($MN)
Table 42 Europe Viral Molecular Diagnostics Market Outlook, By Application (2013-2022) ($MN)
Table 43 Europe Viral Molecular Diagnostics Market Outlook, By Respiratory Syncytial Virus (2013-2022) ($MN)
Table 44 Europe Viral Molecular Diagnostics Market Outlook, By Hepatitis (2013-2022) ($MN)
Table 45 Europe Viral Molecular Diagnostics Market Outlook, By AIDS (2013-2022) ($MN)
Table 46 Europe Viral Molecular Diagnostics Market Outlook, By Influenza (2013-2022) ($MN)
Table 47 Europe Viral Molecular Diagnostics Market Outlook, By Other Applications (2013-2022) ($MN)
Table 48 Europe Viral Molecular Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
Table 49 Europe Viral Molecular Diagnostics Market Outlook, By Real time PCR (RT-PCR) (2013-2022) ($MN)
Table 50 Europe Viral Molecular Diagnostics Market Outlook, By Polymerase chain reaction (PCR) (2013-2022) ($MN)
Table 51 Europe Viral Molecular Diagnostics Market Outlook, By Nucleic Acid Sequence Based Amplification (2013-2022) ($MN)
Table 52 Europe Viral Molecular Diagnostics Market Outlook, By Other Molecular Diagnostic methods (2013-2022) ($MN)
Table 53 Europe Viral Molecular Diagnostics Market Outlook, By End User (2013-2022) ($MN)
Table 54 Europe Viral Molecular Diagnostics Market Outlook, By Academic Institutions (2013-2022) ($MN)
Table 55 Europe Viral Molecular Diagnostics Market Outlook, By Hospitals (2013-2022) ($MN)
Table 56 Europe Viral Molecular Diagnostics Market Outlook, By Ambulatory clinics (2013-2022) ($MN)
Table 57 Europe Viral Molecular Diagnostics Market Outlook, By Diagnostic Laboratories (2013-2022) ($MN)
Table 58 Europe Viral Molecular Diagnostics Market Outlook, By Product Type (2013-2022) ($MN)
Table 59 Europe Viral Molecular Diagnostics Market Outlook, By Reagents (2013-2022) ($MN)
Table 60 Europe Viral Molecular Diagnostics Market Outlook, By Instrument (2013-2022) ($MN)
Table 61 Europe Viral Molecular Diagnostics Market Outlook, By Other Products (2013-2022) ($MN)
Table 62 Asia Pacific Viral Molecular Diagnostics Market Outlook, By Application (2013-2022) ($MN)
Table 63 Asia Pacific Viral Molecular Diagnostics Market Outlook, By Respiratory Syncytial Virus (2013-2022) ($MN)
Table 64 Asia Pacific Viral Molecular Diagnostics Market Outlook, By Hepatitis (2013-2022) ($MN)
Table 65 Asia Pacific Viral Molecular Diagnostics Market Outlook, By AIDS (2013-2022) ($MN)
Table 66 Asia Pacific Viral Molecular Diagnostics Market Outlook, By Influenza (2013-2022) ($MN)
Table 67 Asia Pacific Viral Molecular Diagnostics Market Outlook, By Other Applications (2013-2022) ($MN)
Table 68 Asia Pacific Viral Molecular Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
Table 69 Asia Pacific Viral Molecular Diagnostics Market Outlook, By Real time PCR (RT-PCR) (2013-2022) ($MN)
Table 70 Asia Pacific Viral Molecular Diagnostics Market Outlook, By Polymerase chain reaction (PCR) (2013-2022) ($MN)
Table 71 Asia Pacific Viral Molecular Diagnostics Market Outlook, By Nucleic Acid Sequence Based Amplification (2013-2022) ($MN)
Table 72 Asia Pacific Viral Molecular Diagnostics Market Outlook, By Other Molecular Diagnostic methods (2013-2022) ($MN)
Table 73 Asia Pacific Viral Molecular Diagnostics Market Outlook, By End User (2013-2022) ($MN)
Table 74 Asia Pacific Viral Molecular Diagnostics Market Outlook, By Academic Institutions (2013-2022) ($MN)
Table 75 Asia Pacific Viral Molecular Diagnostics Market Outlook, By Hospitals (2013-2022) ($MN)
Table 76 Asia Pacific Viral Molecular Diagnostics Market Outlook, By Ambulatory clinics (2013-2022) ($MN)
Table 77 Asia Pacific Viral Molecular Diagnostics Market Outlook, By Diagnostic Laboratories (2013-2022) ($MN)
Table 78 Asia Pacific Viral Molecular Diagnostics Market Outlook, By Product Type (2013-2022) ($MN)
Table 79 Asia Pacific Viral Molecular Diagnostics Market Outlook, By Reagents (2013-2022) ($MN)
Table 80 Asia Pacific Viral Molecular Diagnostics Market Outlook, By Instrument (2013-2022) ($MN)
Table 81 Asia Pacific Viral Molecular Diagnostics Market Outlook, By Other Products (2013-2022) ($MN)
Table 82 Rest of the World Viral Molecular Diagnostics Market Outlook, By Application (2013-2022) ($MN)
Table 83 Rest of the World Viral Molecular Diagnostics Market Outlook, By Respiratory Syncytial Virus (2013-2022) ($MN)
Table 84 Rest of the World Viral Molecular Diagnostics Market Outlook, By Hepatitis (2013-2022) ($MN)
Table 85 Rest of the World Viral Molecular Diagnostics Market Outlook, By AIDS (2013-2022) ($MN)
Table 86 Rest of the World Viral Molecular Diagnostics Market Outlook, By Influenza (2013-2022) ($MN)
Table 87 Rest of the World Viral Molecular Diagnostics Market Outlook, By Other Applications (2013-2022) ($MN)
Table 88 Rest of the World Viral Molecular Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
Table 89 Rest of the World Viral Molecular Diagnostics Market Outlook, By Real time PCR (RT-PCR) (2013-2022) ($MN)
Table 90 Rest of the World Viral Molecular Diagnostics Market Outlook, By Polymerase chain reaction (PCR) (2013-2022) ($MN)
Table 91 Rest of the World Viral Molecular Diagnostics Market Outlook, By Nucleic Acid Sequence Based Amplification (2013-2022) ($MN)
Table 92 Rest of the World Viral Molecular Diagnostics Market Outlook, By Other Molecular Diagnostic methods (2013-2022) ($MN)
Table 93 Rest of the World Viral Molecular Diagnostics Market Outlook, By End User (2013-2022) ($MN)
Table 94 Rest of the World Viral Molecular Diagnostics Market Outlook, By Academic Institutions (2013-2022) ($MN)
Table 95 Rest of the World Viral Molecular Diagnostics Market Outlook, By Hospitals (2013-2022) ($MN)
Table 96 Rest of the World Viral Molecular Diagnostics Market Outlook, By Ambulatory clinics (2013-2022) ($MN)
Table 97 Rest of the World Viral Molecular Diagnostics Market Outlook, By Diagnostic Laboratories (2013-2022) ($MN)
Table 98 Rest of the World Viral Molecular Diagnostics Market Outlook, By Product Type (2013-2022) ($MN)
Table 99 Rest of the World Viral Molecular Diagnostics Market Outlook, By Reagents (2013-2022) ($MN)
Table 100 Rest of the World Viral Molecular Diagnostics Market Outlook, By Instrument (2013-2022) ($MN)
Table 101 Rest of the World Viral Molecular Diagnostics Market Outlook, By Other Products (2013-2022) ($MN)



【レポートのキーワード】

ウイルス分子診断、RSウイルス、肝炎、リアルタイムPCR、診断技術、PCR、核酸配列

★調査レポート[ウイルス分子診断の世界市場]販売に関する免責事項
★調査レポート[ウイルス分子診断の世界市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆